Cadent Capital Advisors, LLC Eli Lilly & CO Transaction History
Cadent Capital Advisors, LLC
- $317 Million
- Q3 2024
A detailed history of Cadent Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cadent Capital Advisors, LLC holds 475 shares of LLY stock, worth $345,420. This represents 0.13% of its overall portfolio holdings.
Number of Shares
475
Previous 564
15.78%
Holding current value
$345,420
Previous $510,000
17.65%
% of portfolio
0.13%
Previous 0.21%
Shares
5 transactions
Others Institutions Holding LLY
# of Institutions
4,002Shares Held
752MCall Options Held
8.27MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$70.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$53.6 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$47.9 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$37.3 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$24.6 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $691B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...